An angel group or seed fund will help provide capital for an early stage (often pre-revenue) company, usually in exchange for convertible debt or ownership equity.
FDA Programs to Facilitate and Expedite Development of New Drugs
Location
Online/Zoom
Join Dr. Elizabeth Gordon from 12 to 1pm for an engaging and informative Virtual Lunch & Learn series, where we will dive deep into the key aspects of drug development in the U.S. This is the last installment of our 3-part series designed to provide a comprehensive understanding of the critical steps, strategies, and regulatory considerations that drive successful pharmaceutical product development.
This session will present the mechanisms that exist to expedite approval of products to treat life-threatening diseases and conditions. The goal of these programs is to accelerate the availability of new therapies to patients with serious conditions, especially when there are no satisfactory alternatives. The benefits of each program will be reviewed, and the data requirements for successful application will be discussed.